Holder snapshot 7 signals
Share change
+2,849,243
Put/Call ratio
0%
SEC-reported price per share
$0.51
Number of holders
38
Value change
+$1,060,111
Number of buys
10
Open additional details 1 more signal available
Number of sells
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
114,373,343

Security key

753018100

Report period

Q2 2025

Institutions

38

Top holders

10

Ownership snapshot

Top reported holders of RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F Lead comparable stake: 0.7% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 0.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership Top 5
VANGUARD GROUP INC 0.7%
Nan Fung Group Holdings Ltd 0.43%
Alphabet Inc. 0.39%
UNITED SERVICES AUTOMOBILE ASSOCI... 0.26%
TAKEDA PHARMACEUTICAL CO LTD 0.18%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
0.7%
$1,007,596
799,679 shares
31 Mar 2025
Nan Fung Group Holdings Ltd
13F
Company
13F
0.43%
$621,916
493,584 shares
31 Mar 2025
Alphabet Inc.
13F
Company
13F
0.39%
$565,100
448,492 shares
31 Mar 2025
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
13F
0.26%
$411,730
302,743 shares
31 Mar 2025
TAKEDA PHARMACEUTICAL CO LTD
13F
Company
13F
0.18%
$256,019
203,190 shares
31 Mar 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.17%
$247,286
196,217 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
38
Shares
6,458,632
Rows available
38
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
38
Q2 2025 holders
38
Holder diff
0
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .